Preanaesthetic blood tests in cats and dogs older than 8 years: anaesthetists' prediction and peri-anaesthetic changes.

OBJECTIVE: To evaluate the anaesthetist's ability to predict abnormalities in preanaesthetic blood test results obtained from cats and dogs older than 8 years and to describe the impact of these preanaesthetic blood test results on the American Society Anesthesiologists (ASA) physical status classification, anaesthetic protocol and procedures. STUDY DESIGN: Observational, prospective, clinical multi-centre study. ANIMALS: A total of 333 cats and dogs. METHODS: After a clinical examination and review of the animal´s clinical history the anaesthetist completed the first part of a set of questions including ASA status and anticipated abnormalities in blood tests. After this, blood results were presented, and the anaesthetist completed the second part of the set of questions, including changes in ASA status or anaesthetic protocol, and procedure delay or cancellation. Preanaesthetic blood tests included: haematocrit, total proteins, electrolytes, glucose, lactate, urea and creatinine. Examiners were classified as senior clinicians, clinicians, anaesthesia residents or nurses, and interns. For statistical analysis, the chi-square test was used. A p value < 0.05 was considered significant. RESULTS: The ASA status increased in three dogs and one cat (1.2%); in two of them abnormalities were not expected by the examiner. The anaesthetic protocol changed in seven animals (2.1%); the most common change related to fluid therapy. Anaesthesia was delayed in two dogs (0.6%) to administer intravenous fluid therapy. No cases were cancelled. Abnormalities were more commonly found [37 out of 58 assessments (approximately 64%)] when the anaesthetist predicted them compared to when they were unexpected [49 of 275 assessments (approximately 18%); p < 0.001]. CONCLUSIONS AND CLINICAL RELEVANCE: Routine non-targeted blood tests in cats and dogs older than 8 years led to few changes in the anaesthetic management, and anaesthetists correctly predicted blood test results in most cases.

Comparison of two topical treatments of gastro-oesophageal regurgitation in dogs during general anaesthesia.

OBJECTIVE: To determine whether suction, lavage and instillation of sodium bicarbonate, following a gastro-oesophageal regurgitation event under general anaesthesia, would alter oesophageal pH to a greater degree than when lavage was not used. STUDY DESIGN: Prospective, randomised, clinical study. ANIMALS: A group of 22 client-owned dogs. METHODS: Dogs presenting with gastro-oesophageal regurgitation (GOReg) under general anaesthesia were randomised into groups: no lavage (G1) or lavage (G2). All dogs underwent oesophageal suctioning until no further regurgitant material was retrieved. Dogs in G2 had oesophageal lavage with tap water until the suctioned water was clear. All dogs then had 4.2% sodium bicarbonate (0.6 mL kg-1) instilled into the oesophagus. An oesophageal pH probe was placed to record pH immediately after: GOReg (T1), suctioning (T2), lavage of the oesophagus (T3; G2 only) and sodium bicarbonate instillation (T4). Categorical data were analysed using Fisher's exact test, and continuous data were analysed using either the two-sample t-test or the Wilcoxon rank-sum test. Parametric data are reported as mean ± standard deviation and non-parametric data as median (interquartile range). A p value < 0.05 was considered significant. RESULTS: Oesophageal pH was low in both groups immediately after GOReg [G1: 2.95 (2.20-4.18), G2: 3.29 (1.41-4.03)] but oesophageal pH was not significantly different between groups at T1, T2 and T4. Oesophageal lavage significantly increased pH but the overall change in pH following bicarbonate administration (T2-T4) was not significantly different between groups [G1: 3.16 ± 1.52, G2: 3.52 ± 1.47]. No adverse events following GOReg were recorded. CONCLUSIONS AND CLINICAL RELEVANCE: Both groups had similar and clinically important increases in oesophageal pH. Although oesophageal lavage increased pH, this did not affect the final oesophageal pH when sodium bicarbonate was instilled and therefore may be an unnecessary step.

Opioid-sparing effect of a medetomidine constant rate infusion during thoraco-lumbar hemilaminectomy in dogs administered a ketamine infusion.

OBJECTIVE: To evaluate the perioperative opioid-sparing effect of a medetomidine (MED) infusion compared to a saline (SAL) infusion in otherwise healthy dogs undergoing thoraco-lumbar hemilaminectomy surgery. STUDY DESIGN: Randomized, partially blinded, clinical study. ANIMALS: A total of 44 client-owned adult dogs. METHODS: All dogs were administered a 1 µg kg-1 MED loading dose, followed by a 1.7 µg kg-1 hour-1 constant rate infusion (CRI) intravenously or equivalent volumes of SAL. Infusions were started 10-15 minutes before surgical incision and continued throughout the surgical procedure. All dogs were administered a standardized anaesthetic and analgesic protocol (including a ketamine CRI). Multiparametric monitoring, including invasive arterial blood pressure, was performed. A trained investigator, unaware of the treatment, performed pain scores for 4 hours postoperatively. Rescue analgesia consisted of fentanyl administered intraoperatively and methadone postoperatively. Data were tested for normality and analysed with Fisher's exact test, Mann-Whitney U-test, analysis of variance and Kaplan-Meier survival analysis. Data are shown as median (interquartile range) and p-value was set at < 0.05. RESULTS: The total dose of fentanyl was significantly lower with MED 0 (0-0.8) µg kg-1 hour-1 compared to SAL 3 (1.8-5.3) µg kg-1 hour-1 (p = 0.004). In the MED group, one dog compared to 12 dogs in the SAL group required a fentanyl CRI (p = 0.001). There were no statistically significant differences between groups regarding the total dose of methadone administered. CONCLUSIONS AND CLINICAL RELEVANCE: The addition of a low-dose medetomidine CRI to the anaesthetic protocol decreased the need for a fentanyl CRI in otherwise healthy dogs undergoing thoraco-lumbar hemilaminectomy surgery during administration of a ketamine CRI.

Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9.

We report for the first time that expression of the novel IL-1 cytokine receptor IL-1Rrp2 (IL-1R6) is unique to DCs within the human myelomonocytic lineage. IL-1Rrp2 was expressed by monocyte-derived dendritic cells (MDDCs) which was dose-dependently increased by IL-4 and correlated with increased numbers of differentiated MDDCs. Human plasmacytoid DCs also express IL-1Rrp2 but the receptor is not expressed by either myeloid DC type 1 (mDC1) or mDC2 cells. We also show that IL-1F8 or IL-1F9 cytokines, which signal through IL-1Rrp2, induce maturation of MDDCs, as measured by increased expression of HLA-DR and CD83 and decreased expression of CD1a. Furthermore, IL-1F8 stimulated increased CD40 and CD80 expression and IL-18 and IL-12 p70 production by MDDCs, which induced proliferation of IFN-γ-producing CD3(+) lymphocytes (indicative of inflammatory Th1 subsets). IL-1F8 and IL-1F2 were equipotent in their ability to stimulate IL-18 secretion from MDDCs but IL-1F8 was not as potent as IL-1F2 in stimulating secretion of IL-12p70 from MDDCs or inducing lymphocyte proliferation Therefore, IL-1Rrp2 expression by some DC subsets may have an important function in the human immune response in vivo via its role in differentiation of inflammatory Th1 lymphocytes.